Detalhe da pesquisa
1.
Wnt/ß-Catenin Signaling Contributes to Paclitaxel Resistance in Bladder Cancer Cells with Cancer Stem Cell-Like Properties.
Int J Mol Sci
; 23(1)2021 Dec 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-35008872
2.
Radium-223 international early access program: results from the Spanish subset.
Future Oncol
; 14(1): 41-50, 2018 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-29232987
3.
Maintenance therapy with vinflunine plus best supportive care versus best supportive care alone in patients with advanced urothelial carcinoma with a response after first-line chemotherapy (MAJA; SOGUG 2011/02): a multicentre, randomised, controlled, open-label, phase 2 trial.
Lancet Oncol
; 18(5): 672-681a, 2017 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-28389316
4.
Management of adverse events of targeted therapies in normal and special patients with metastatic renal cell carcinoma.
Cancer Metastasis Rev
; 31 Suppl 1: S19-27, 2012 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-22821550
5.
SEOM SOGUG clinical guideline for treatment of kidney cancer (2022).
Clin Transl Oncol
; 25(9): 2732-2748, 2023 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-37556095
6.
A phase II randomised trial of abiraterone acetate plus prednisone in combination with docetaxel or docetaxel plus prednisone after disease progression to abiraterone acetate plus prednisone in patients with metastatic castration-resistant prostate cancer: The ABIDO-SOGUG trial.
Eur J Cancer
; 175: 110-119, 2022 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-36099670
7.
The Challenge of Managing Bladder Cancer and Upper Tract Urothelial Carcinoma: A Review with Treatment Recommendations from the Spanish Oncology Genitourinary Group (SOGUG).
Target Oncol
; 14(1): 15-32, 2019 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-30694442
8.
PROREPAIR-B: A Prospective Cohort Study of the Impact of Germline DNA Repair Mutations on the Outcomes of Patients With Metastatic Castration-Resistant Prostate Cancer.
J Clin Oncol
; 37(6): 490-503, 2019 02 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-30625039
9.
Obatoclax and Paclitaxel Synergistically Induce Apoptosis and Overcome Paclitaxel Resistance in Urothelial Cancer Cells.
Cancers (Basel)
; 10(12)2018 Dec 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-30563080
10.
Weekly cabazitaxel plus prednisone is effective and less toxic for 'unfit' metastatic castration-resistant prostate cancer: Phase II Spanish Oncology Genitourinary Group (SOGUG) trial.
Eur J Cancer
; 87: 30-37, 2017 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-29102858
11.
Recent advances in genitourinary tumors: A review focused on biology and systemic treatment.
Crit Rev Oncol Hematol
; 113: 171-190, 2017 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-28427506
12.
Functional PTGS2 polymorphism-based models as novel predictive markers in metastatic renal cell carcinoma patients receiving first-line sunitinib.
Sci Rep
; 7: 41371, 2017 01 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-28117391
13.
Novel potential predictive markers of sunitinib outcomes in long-term responders versus primary refractory patients with metastatic clear-cell renal cell carcinoma.
Oncotarget
; 8(18): 30410-30421, 2017 May 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-28423742
14.
Loss of PKCδ Induces Prostate Cancer Resistance to Paclitaxel through Activation of Wnt/ß-Catenin Pathway and Mcl-1 Accumulation.
Mol Cancer Ther
; 15(7): 1713-25, 2016 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-27196755
15.
SNPs associated with activity and toxicity of cabazitaxel in patients with advanced urothelial cell carcinoma.
Pharmacogenomics
; 17(5): 463-71, 2016 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-27020167
16.
Updated recommendations from the Spanish Oncology Genitourinary Group for the treatment of patients with metastatic castration-resistant prostate cancer.
Crit Rev Oncol Hematol
; 96(2): 308-18, 2015 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-26100652
17.
Post-contrast acute kidney injury in cancer patients. / Lesión renal aguda poscontraste en pacientes con cáncer.
Nefrologia (Engl Ed)
; 39(6): 563-567, 2019.
Artigo
em Inglês, Espanhol
| MEDLINE | ID: mdl-31014552
18.
Prostate cancer cell response to paclitaxel is affected by abnormally expressed securin PTTG1.
Mol Cancer Ther
; 13(10): 2372-83, 2014 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-25122070
19.
Cabazitaxel for metastatic castration-resistant prostate cancer: safety data from the Spanish expanded access program.
Expert Opin Drug Saf
; 13(9): 1165-73, 2014 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-25001524
20.
Recommendations from the Spanish Oncology Genitourinary Group for the treatment of patients with metastatic castration-resistant prostate cancer.
Crit Rev Oncol Hematol
; 83(3): 341-52, 2012 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-22285697